Annual EBITDA
$3.22B$1.35B-29.49%
Summary
- Current Value
- As of today, VTRS annual EBITDA is $3.22B, down -29.49% on
- Historical Performance
- VTRS annual EBITDA is down -39.93% over the past 3 years, down -9.88% over the past 5 years
- All-Time High Comparison
- VTRS annual EBITDA is currently -39.93% below its historical high of $5.36B set on
- 3-Year Low Comparison
- VTRS annual EBITDA is at its 3-year low
- Sector Comparison
- VTRS annual EBITDA is higher than 96.47% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.22B | -29.5% | -39.9% | -9.9% | +150.3% | |
| Quarterly EBITDA | $1.15B | +10.7% | -4.3% | -31.8% | +173.7% | |
| TTM EBITDA | $4.23B | +7.4% | -16.9% | -19.0% | +190.5% | |
| Price | $16.23 | +51.8% | +45.0% | +8.6% | -15.6% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $14.29B | -2.8% | -11.6% | +19.7% | +162.3% | |
| Annual EPS | -$3.00 | -464.9% | -275.9% | -169.4% | -541.5% | |
| $423.50M | -77.2% | -83.1% | -68.8% | -51.0% | ||
| Annual Net Income | -$3.51B | -454.2% | -269.1% | -424.7% | -1117.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.36B | N/A | -39.9% |
| 5Y | $5.36B | -39.9% | |
| All | $5.36B | -39.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.22B | at low | |
| 5Y | $3.22B | at low | |
| All | $2.32M | >+9999.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of VTRS?
- As of today, VTRS annual EBITDA is $3.22B
- What is 1-year change in VTRS annual EBITDA?
- VTRS annual EBITDA is down -29.49% year-over-year
- What is 3-year change in VTRS annual EBITDA?
- VTRS annual EBITDA is down -39.93% over the past 3 years
- How far is VTRS annual EBITDA from its all-time high?
- VTRS annual EBITDA is currently -39.93% below its historical high of $5.36B set on December 31, 2022
- How does VTRS annual EBITDA rank versus sector peers?
- VTRS annual EBITDA is higher than 96.47% of companies in Healthcare sector
- When is VTRS next annual earnings release?
- As of today, the next annual earnings release for VTRS has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$1.15B$126.30M+12.35%
Summary
- Current Value
- As of today, VTRS quarterly EBITDA is $1.15B, up +12.35% on
- Historical Performance
- VTRS quarterly EBITDA is up +10.71% year-over-year, down -4.28% over the past 3 years
- All-Time High Comparison
- VTRS quarterly EBITDA is currently -31.79% below its historical high of $1.68B set on
- 3-Year Low Comparison
- VTRS quarterly EBITDA is +46.25% above its 3-year low of $785.80M reached on
- Sector Comparison
- VTRS quarterly EBITDA is higher than 96.86% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.15B | +12.3% | +10.7% | -4.3% | -31.8% | |
| Annual EBITDA | $3.22B | – | -29.5% | -39.9% | -9.9% | |
| TTM EBITDA | $4.23B | +2.7% | +7.4% | -16.9% | -19.0% | |
| Price | $16.23 | -6.0% | +51.8% | +45.0% | +8.6% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $3.76B | +6.9% | +5.0% | -3.8% | -17.8% | |
| Quarterly EPS | -$0.10 | -168.0% | -2517.9% | -146.5% | +55.8% | |
| $121.60M | -64.9% | -66.2% | -76.3% | -66.9% | ||
| Quarterly Net Income | -$118.80M | -167.3% | -2482.6% | -145.0% | +57.5% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.15B | at high | |
| 3Y | $1.22B | -5.9% | |
| 5Y | $1.68B | N/A | -31.8% |
| All | $1.68B | -31.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.01B | +14.3% | |
| 3Y | $785.80M | +46.3% | |
| 5Y | $785.80M | +46.3% | |
| All | -$56.49M | +2134.2% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of VTRS?
- As of today, VTRS quarterly EBITDA is $1.15B
- What is VTRS quarterly EBITDA most recent change?
- VTRS quarterly EBITDA was up +12.35% on June 30, 2026
- What is 1-year change in VTRS quarterly EBITDA?
- VTRS quarterly EBITDA is up +10.71% year-over-year
- How far is VTRS quarterly EBITDA from its all-time high?
- VTRS quarterly EBITDA is currently -31.79% below its historical high of $1.68B set on June 30, 2021
- How does VTRS quarterly EBITDA rank versus sector peers?
- VTRS quarterly EBITDA is higher than 96.86% of companies in Healthcare sector
- When is VTRS next earnings release?
- The next earnings release for VTRS is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$4.23B$111.20M+2.70%
Summary
- Current Value
- As of today, VTRS TTM EBITDA is $4.23B, up +2.70% on
- Historical Performance
- VTRS TTM EBITDA is up +7.41% year-over-year, down -16.93% over the past 3 years
- All-Time High Comparison
- VTRS TTM EBITDA is currently -31.77% below its historical high of $6.20B set on
- 3-Year Low Comparison
- VTRS TTM EBITDA is +14.75% above its 3-year low of $3.69B reached on
- Sector Comparison
- VTRS TTM EBITDA is higher than 96.86% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.23B | +2.7% | +7.4% | -16.9% | -19.0% | |
| Annual EBITDA | $3.22B | – | -29.5% | -39.9% | -9.9% | |
| Quarterly EBITDA | $1.15B | +12.3% | +10.7% | -4.3% | -31.8% | |
| Price | $16.23 | -6.0% | +51.8% | +45.0% | +8.6% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $14.75B | +1.2% | +4.9% | -5.1% | -5.4% | |
| TTM EPS | -$0.36 | -37.9% | +87.7% | -123.4% | +80.2% | |
| $1.07B | -18.1% | -9.2% | -49.1% | -2.6% | ||
| TTM Net Income | -$410.70M | -38.5% | +88.2% | -122.2% | +79.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.23B | at high | |
| 3Y | $5.10B | N/A | -16.9% |
| 5Y | $6.20B | -31.8% | |
| All | $6.20B | -31.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.79B | +11.8% | |
| 3Y | $3.69B | +14.8% | |
| 5Y | $3.69B | +14.8% | |
| All | -$56.49M | +7591.9% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of VTRS?
- As of today, VTRS TTM EBITDA is $4.23B
- What is VTRS TTM EBITDA most recent change?
- VTRS TTM EBITDA was up +2.70% on June 30, 2026
- What is 1-year change in VTRS TTM EBITDA?
- VTRS TTM EBITDA is up +7.41% year-over-year
- How far is VTRS TTM EBITDA from its all-time high?
- VTRS TTM EBITDA is currently -31.77% below its historical high of $6.20B set on December 31, 2021
- How does VTRS TTM EBITDA rank versus sector peers?
- VTRS TTM EBITDA is higher than 96.86% of companies in Healthcare sector
- When is VTRS next earnings release?
- The next earnings release for VTRS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- VTRS Official Website www.viatris.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1792044/000179204426000013/0001792044-26-000013-index.htm
- VTRS Profile on Yahoo Finance finance.yahoo.com/quote/VTRS
- VTRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtrs
